World Health Organization grants name ‘Seliforant’ to Sensorion’s SENS-111 treatment. pdfRead

Sensorion annonce le renouvellement de son label " entreprise innovante " accordé par Bpifrance. pdfLire

Mise à disposition du Rapport Financier annuel 2017. pdfLire

Sensorion and Uconn Health Announce Identification of First Potential Biomarker for Noise-Induced Hearing Loss. pdfRead

Sensorion’s SENS-401 Reduces Hearing Loss in Preclinical Study When Oral Administration Initiated Up to Four Days after Acoustic Trauma. pdfRead

Pipeline

2018 08 Pipeline

Enregistrer

Patient center

Corporate presentation

Next events